Journal of Medicinal Chemistry

Oncology & Cancer

Fullerene compounds will help in the fight against lung cancer

A team of scientists from Skoltech Center for Energy Science and Technology, the Institute for Problems of Chemical Physics of Russian Academy of Sciences and National Taiwan University has discovered that fullerene compounds ...

Diseases, Conditions, Syndromes

New vaccine targets killer disease tuberculosis

There is only one existing vaccine for TB and it is not effective in adults. Researchers at the Centenary Institute and University of Sydney will next test their new vaccine in clinical trials with humans.

Oncology & Cancer

A new approach to targeting cancer cells

A University of California, Riverside, research team has come up with a new approach to targeting cancer cells that circumvents a challenge faced by currently available cancer drugs.

Diseases, Conditions, Syndromes

Researchers create molecules with strong anti-Zika virus potential

The Zika virus is widely known for causing microcephaly and other brain defects in the fetuses of pregnant, infected women. Currently, there are no approved antiviral therapies specifically designed to treat Zika, but researchers ...

Autism spectrum disorders

Compound improves social interaction in autism mouse model

Children with autism often find social interactions awkward, leaving them isolated. Now in a study appearing in ACS' Journal of Medicinal Chemistry, scientists report that they have discovered a first-of-its-kind compound ...

page 2 from 7